Filing Details
- Accession Number:
- 0001209191-15-009464
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-04 16:51:38
- Reporting Period:
- 2015-02-02
- Filing Date:
- 2015-02-04
- Accepted Time:
- 2015-02-04 16:51:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1610876 | Jeffrey Chodakewitz | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp Gmda, Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-02-02 | 300 | $108.64 | 84,200 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-02-02 | 788 | $109.80 | 83,412 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-02-02 | 100 | $110.85 | 83,312 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Chodakewitz's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $108.64 (range $108.30 to $109.24).
- Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $109.80 (range $109.42 to $110.37).
Billionaire Hedge Funds
